Dr. Ramya Dwivedi

Dr. Ramya Dwivedi

Feature Writer

Ph.D. Biotechnology

Ramya has a Ph.D. in Biotechnology from the National Chemical Laboratories (CSIR-NCL), in Pune. Her work consisted of functionalizing nanoparticles with different molecules of biological interest, studying the reaction system and establishing useful applications.

She also has had exposure to research in molecular biology, immunology, evolutionary biology, chemistry, AFM imaging and analysis, and spectroscopy. Her interests cover interdisciplinary sciences.

She enjoyed teaching ‘Physics in Nanoscience and Nanotechnology’ as an Assistant Professor at SRM University. After a short period there, she pursued research further as the prestigious CSIR Nehru Science Post Doctoral Fellow in the field of Nanosciences.

Her research helped her skill for writing manuscripts, news articles, and reviews. She has also contributed as a peer reviewer for journals from RSC and ACS publications. After a maternity break and raising two daughters, Ramya is now working to get back into learning, research, and writing.

When Ramya is not immersed in a book, she loves to cook, travel and play with her daughters. She lives in Chennai. She is also a budding gardener. She strongly believes in doing her bit for the environment and in healthy living.

She has recently finished an online course: ‘Writing in the Sciences’, offered by Stanford University. Presently Ramya sees her freelance writing as a primer to her endeavors in science.

Articles from Ramya

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Virus-like particles as delivery vehicles for gene-editing

Virus-like particles as delivery vehicles for gene-editing

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Association of obstructive sleep apnea with hospitalization due to COVID-19

Association of obstructive sleep apnea with hospitalization due to COVID-19

Oral bacteria-based SARS-CoV-2 vaccine platform

Oral bacteria-based SARS-CoV-2 vaccine platform

COVID-19 vaccine appears safe in children aged 5–11 Years

COVID-19 vaccine appears safe in children aged 5–11 Years